Vol. 44 No. 14
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
Innovations in glaucoma poised for breakthrough in 2026 (and what might hold them back)
3
FDA approvals in 2025: What changed and why it matters for ophthalmologists
4
PRIMAvera study: Central vision improvement with subretinal implant
5